Koichi Onodera

549 total citations
38 papers, 264 citations indexed

About

Koichi Onodera is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Koichi Onodera has authored 38 papers receiving a total of 264 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Oncology, 14 papers in Hematology and 9 papers in Genetics. Recurrent topics in Koichi Onodera's work include Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Koichi Onodera is often cited by papers focused on Viral-associated cancers and disorders (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Koichi Onodera collaborates with scholars based in Japan, United States and Netherlands. Koichi Onodera's co-authors include Noriko Fukuhara, Yasushi Onishi, Hideo Harigae, Tohru Fujiwara, Satoshi Ichikawa, Hisayuki Yokoyama, Masamitsu Hatakenaka, Yoko Okitsu, Ritsuko Shimizu and Masayuki Yamamoto and has published in prestigious journals such as New England Journal of Medicine, Blood and PLoS ONE.

In The Last Decade

Koichi Onodera

28 papers receiving 262 citations

Peers

Koichi Onodera
TRDJ Radstake Netherlands
Koichi Onodera
Citations per year, relative to Koichi Onodera Koichi Onodera (= 1×) peers TRDJ Radstake

Countries citing papers authored by Koichi Onodera

Since Specialization
Citations

This map shows the geographic impact of Koichi Onodera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koichi Onodera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koichi Onodera more than expected).

Fields of papers citing papers by Koichi Onodera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koichi Onodera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koichi Onodera. The network helps show where Koichi Onodera may publish in the future.

Co-authorship network of co-authors of Koichi Onodera

This figure shows the co-authorship network connecting the top 25 collaborators of Koichi Onodera. A scholar is included among the top collaborators of Koichi Onodera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koichi Onodera. Koichi Onodera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ichikawa, Satoshi, Koichi Onodera, Yoko Okitsu, et al.. (2025). Methotrexate-associated Angioimmunoblastic T-cell Lymphoma Presenting with Acute Kidney Injury. Internal Medicine. 65(1). 167–172.
2.
Ishida, Masaharu, Koichi Onodera, Shuichi Aoki, et al.. (2024). Laparoscopic excision of accessory spleen for recurrent autoimmune hemolytic anemia after splenectomy: a case report. Surgical Case Reports. 10(1). 110–110. 1 indexed citations
3.
Ichikawa, Satoshi, Hiroshi Nakamura, Ryo Nakagawa, et al.. (2024). Successful Cord Blood Transplantation for Myeloid/Natural Killer Precursor Acute Leukemia: A Case Report and Literature Review. Internal Medicine. 64(8). 1235–1239.
4.
Imai, Hiroo, et al.. (2024). Nivolumab-induced Thrombotic Thrombocytopenic Purpura in Patients with Gastric Tube Cancer. Internal Medicine. 63(19). 2667–2671. 1 indexed citations
5.
Onozawa, Masahiro, Shigeru Kusumoto, Yuho Najima, et al.. (2024). Outcomes of Cessation of Nucleos(t)ide Analog Administration on Hepatitis B Virus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation: A Nationwide Retrospective Study. Transplantation and Cellular Therapy. 30(3). 330.e1–330.e8.
7.
Ichikawa, Satoshi, Ryo Nakagawa, Shunsuke Hatta, et al.. (2024). Successful Allogeneic Hematopoietic Stem Cell Transplantation for Nodal Epstein-Barr Virus-positive T/NK-cell Lymphoma. Internal Medicine. 64(12). 1888–1892.
8.
Onishi, Yasushi, Takehiko Mori, Hirohito Yamazaki, et al.. (2023). Comparison of Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide versus Umbilical Cord Blood Transplantation in Adult Patients with Aplastic Anemia. Transplantation and Cellular Therapy. 29(12). 766.e1–766.e8. 2 indexed citations
9.
Ichikawa, Satoshi, Yasushi Onishi, Noriko Fukuhara, et al.. (2022). Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation. Journal of Clinical and Experimental Hematopathology. 62(3). 164–168.
10.
Fujiwara, Tohru, Koya Ono, Chie Suzuki, et al.. (2022). Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome. Scientific Reports. 12(1). 14562–14562. 14 indexed citations
11.
Onishi, Yasushi, Koichi Onodera, Noriko Fukuhara, et al.. (2022). Unrelated cord blood transplantation for adult-onset EBV-associated T-cell and NK-cell lymphoproliferative disorders. International Journal of Hematology. 115(6). 873–881.
12.
Ono, Koya, Tohru Fujiwara, Kei Saito, et al.. (2022). Congenital sideroblastic anemia model due to ALAS2 mutation is susceptible to ferroptosis. Scientific Reports. 12(1). 9024–9024. 13 indexed citations
13.
Onodera, Koichi, Yasushi Onishi, Jun Inoue, et al.. (2021). Second direct-acting antiviral therapy for hepatitis C virus infection after umbilical cord blood transplantation: A case report. Journal of Infection and Chemotherapy. 27(8). 1230–1233. 1 indexed citations
14.
Kawasaki, Yoshihide, Naoki Kawamorita, Shinichi Yamashita, et al.. (2021). BK Virus-Associated Urothelial Carcinoma in a Patient with Peripheral Blood Stem Cell Transplantation for Acute Lymphoblastic Leukemia: A Case Report. Case Reports in Oncology. 14(1). 8–12.
15.
Ichikawa, Satoshi, Noriko Fukuhara, Kei Saito, et al.. (2020). Successful treatment of methotrexate-associated classical Hodgkin lymphoma with brentuximab vedotin-combined chemotherapy: a case series. International Journal of Hematology. 111(5). 667–672. 8 indexed citations
16.
Ichikawa, Satoshi, Noriko Fukuhara, Kei Saito, et al.. (2020). Successful Treatment of Primary Refractory Angioimmunoblastic T-cell Lymphoma With Cord Blood Transplantation. Clinical Lymphoma Myeloma & Leukemia. 20(11). e926–e929. 1 indexed citations
17.
Ichikawa, Satoshi, Noriko Fukuhara, Yoko Okitsu, et al.. (2019). Long-term survival after cord blood transplantation for acute myeloid leukemia complicated with disseminated fusariosis. Journal of Infection and Chemotherapy. 26(2). 292–295. 1 indexed citations
18.
Onishi, Yasushi, Koichi Onodera, Masahiro Kobayashi, et al.. (2018). Umbilical Cord Blood Transplantation Using Reduced-Intensity Conditioning without Antithymocyte Globulin in Adult Patients with Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 25(2). e55–e59. 13 indexed citations
19.
Nishiwaki, Satoshi, Takumi Sugimoto, Koichi Onodera, et al.. (2017). Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia. Medicine. 96(50). e9160–e9160. 4 indexed citations
20.
Goto, Tatsunori, Katsuya Ikuta, Yoshihiro Inamoto, et al.. (2012). Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron. International Journal of Hematology. 97(1). 125–134. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026